We have cloned a novel human kinase encoding gene (STKI5/BTAKaurora2), harbored on chromosome 20q13 that is amplified/overexpressed in many different human tumor cell types (Sen et al, Oncogene 14:2195-2200; Zhoui Kuang, Zhong, Kuo, Gray, Brinkley and Sen. Nature Genetics 20:189-193, 1998). Over-expression of this gene induces abnormal centrosome duplication/distribution, aneuploidy and tumorigenic transformation in mammalian cells. Over expression of STK1 5 has been detected in about 50 percent of unselected primary colon tumors and gene amplification detected in about 12 percent of unselected primary breast tumors. Over all goals of this project include elucidating the STK1 5 pathway that is involved in maintaining genomic stability and induction of aneuploidy in normal and cancer cells respectively. We also propose to evaluate the patho-genetic significance of STK1 5 protein and STK1 5 interacting proteins in human colon cancer cells.
The specific aims of this project are to: 1. Identify the interactions of STK1 5 kinase with its potential regulator and effector proteins through the G2-M phase of the cell division cycle. The results would help understand the role of these interactions in G2-M-Anaphase progression of cells. 2. Investigate amino acid structural requirements and post-translational modifications required for a) STK1 5 sub-cellular localization including targeting to centrosomes, and b) binding to interacting proteins. Results would help elucidate the biochemical mechanisms regulating STK1 5 localization and their functional relevance. 3. Investigate the role of STK1 5 and its interacting proteins in the regulation of centrosome function and chromosomal stability in proliferating cells in vivo through co-transfection experiments with appropriate wild type and mutant expression constructs. The findings of these studies are expected to elucidate the pathway that involves STK1 5 in maintaining genomic stability as well as in activating changes leading to transformation of cells due to abnormally elevated expression of the gene. 4. Determine the expression profiles of STK15 kinase and its interacting proteins in colon cancer specimens of different histological grades and stages with or without chromosomal instability phenotypes. Results would help assess the diagnostic and prognostic significance of STK1 5 pathway in this cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA089716-02
Application #
6522641
Study Section
Pathology B Study Section (PTHB)
Program Officer
Thurin, Magdalena
Project Start
2001-09-26
Project End
2005-08-31
Budget Start
2002-09-17
Budget End
2003-08-31
Support Year
2
Fiscal Year
2002
Total Cost
$249,000
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Pathology
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Fujii, Satoshi; Srivastava, Vibhuti; Hegde, Apurva et al. (2015) Regulation of AURKC expression by CpG island methylation in human cancer cells. Tumour Biol 36:8147-58
Wang, Jin; Yin, Hailin; Panandikar, Ashwini et al. (2015) Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug. Int J Oncol 47:782-90
Torchia, Enrique C; Zhang, Lei; Huebner, Aaron J et al. (2013) Aurora kinase-A deficiency during skin development impairs cell division and stratification. J Invest Dermatol 133:78-86
Katayama, Hiroshi; Wang, Jin; Treekitkarnmongkol, Warapen et al. (2012) Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell 21:196-211
Katayama, Hiroshi; Sen, Subrata (2011) Functional significance of Aurora kinase A regulatory interactions with p53-ER? complex in human breast cancer cells. Horm Cancer 2:117-24
Katayama, Hiroshi; Sen, Subrata (2010) Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta 1799:829-39
Jiang, Shoulei; Katayama, Hiroshi; Wang, Jin et al. (2010) Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells. Horm Cancer 1:11-20
Mazumdar, Abhijit; Henderson, Ying C; El-Naggar, Adel K et al. (2009) Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck 31:625-34
Torchia, Enrique C; Chen, Yiyun; Sheng, Hong et al. (2009) A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors. Cancer Res 69:7207-15
Park, Hong-Seok; Park, Weon Seo; Bondaruk, Jolanta et al. (2008) Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst 100:1401-11

Showing the most recent 10 out of 23 publications